How effective are these agents for AUD treatment? An expert shares highlights from his 2024 ASCP Annual Meeting Pharmaceutical Pipeline Update presentation.
Mehdi Farokhnia, MD, MPH
Advertisement
Articles by Mehdi Farokhnia, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms
2
Postpartum Psychosis on Trial: What the Lindsay Clancy Case Can Teach Us
3
Xanomeline/Trospium in Treatment-Refractory Bipolar I Disorder With Psychosis: A Case Report of Rapid Agitation Control and Functional Improvement
4
Centanafadine in ADHD: Clinical Significance of the First Triple Reuptake Inhibitor for ADHD
5